Children last in line for COVID-19 vaccine, lack clinical trial representation

The drugmakers establishing the vaccine candidates now in the last of medical testing– Pfizer, Moderna, AstraZeneca and Johnson & & Johnson– all informed Business Insider they plan to evaluate their vaccines in kids, but none offered an approximated timeline of when a vaccine could become available for children.

” Right now Im pretty stressed that we will not have a vaccine readily available for kids by the start of next academic year,” Evan Anderson, MD, an Atlanta pediatrician, told The New York Times.

Kids have yet to be involved in any medical trials for a COVID-19 vaccine, meaning they might have to wait significantly longer than the remainder of the population to be inoculated, according to Business Insider.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by click on this link.

More short articles on pharmacy: Novartis sells $2.1 B in bonds to increase access to its drugs in disadvantaged countriesFDA proposes change to rule on off-label drug useGilead settles kickback accusations for $97M.

Moderna shared its plans to start a pediatric trial with Business Insider, stating it intends to get one underway by the end of 2020, pending regulative approval.

Katie Adams –
Thursday, September 24th, 2020
Print|Email.